ANIXA BIOSCIENCES INC (ANIX) Stock Analyst Earnings Estimates
NASDAQ:ANIX - Nasdaq - US03528H1095 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 510K | -100.00% | 210K | -100.00% | 23.051M | 63.964M 177.49% | 163.18M 155.11% | 904.77M 454.46% | |||||
| EBITDA YoY % growth | -12.75M -28.27% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -12.75M -27.76% | -13.88M -8.86% | -10.85M 21.83% | -14.206M -27.47% | -15.485M -11.96% | -16.388M -5.83% | -17.279M -5.43% | -18.245M -5.59% | 3.757M 120.59% | 43.527M 1,058.56% | 141.5M 225.09% | 881.74M 523.14% | |
| Operating Margin | -2,500.00% | N/A | -5,166.67% | N/A | N/A | N/A | N/A | N/A | 16.30% | 68.05% | 86.71% | 97.45% | |
| EPS YoY % growth | -0.44 0.00% | -0.46 -4.55% | -0.32 30.43% | -0.40 -21.88% | -0.35 11.08% | -0.24 29.41% | -0.24 | 1.18 583.33% | 0.90 -24.14% | 1.55 72.73% | N/A | N/A |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 -2.00% | -0.10 -2.00% | -0.10 -2.00% | -0.10 -13.33% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.499M 3.04% | -3.577M -3.16% | -3.732M -3.90% | -3.81M -20.46% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.09 | -0.09 | 0.00 | -3.81% |
| Q3 2024 Q2Q % growth | -0.10 -25.00% | -0.10 | 0.00 | -3.20% |
| Q2 2024 Q2Q % growth | -0.10 -42.86% | -0.11 | 0.01 | 10.87% |
| Q1 2024 Q2Q % growth | -0.10 -25.00% | -0.09 | -0.01 | -8.93% |
| Q4 2023 Q2Q % growth | -0.09 25.00% | -0.09 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.08 11.11% | -0.09 | 0.01 | 12.85% |
| Q2 2023 Q2Q % growth | -0.07 41.67% | -0.12 | 0.05 | 40.32% |
| Q1 2023 Q2Q % growth | -0.08 38.46% | -0.16 | 0.08 | 50.98% |
| Q4 2022 Q2Q % growth | -0.12 7.69% | -0.11 | -0.01 | -6.95% |
| Q3 2022 Q2Q % growth | -0.09 35.71% | -0.13 | 0.04 | 32.13% |
| Q2 2022 Q2Q % growth | -0.12 -50.00% | -0.13 | 0.01 | 9.50% |
| Q1 2022 Q2Q % growth | -0.13 -44.44% | -0.13 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.13 -44.44% | -0.09 | -0.04 | -41.61% |
| Q3 2021 Q2Q % growth | -0.14 -40.00% | -0.08 | -0.06 | -71.57% |
| Q2 2021 Q2Q % growth | -0.08 33.33% | -0.11 | 0.03 | 25.30% |
| Q1 2021 Q2Q % growth | -0.09 30.77% | -0.11 | 0.02 | 19.79% |
| Q4 2020 Q2Q % growth | -0.09 10.00% | -0.11 | 0.02 | 15.97% |
| Q3 2020 Q2Q % growth | -0.10 9.09% | -0.13 | 0.03 | 21.57% |
| Q2 2020 Q2Q % growth | -0.12 7.69% | -0.13 | 0.01 | 5.88% |
| Q1 2020 Q2Q % growth | -0.13 43.48% | -0.13 | 0.00 | 1.96% |
| Q4 2019 Q2Q % growth | -0.10 | -0.24 | 0.14 | 59.15% |
| Q3 2019 Q2Q % growth | -0.11 | -0.23 | 0.12 | 53.11% |
| Q2 2019 Q2Q % growth | -0.13 | -0.23 | 0.10 | 44.59% |
| Q1 2019 Q2Q % growth | -0.23 | -0.15 | -0.08 | -50.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | -100.00% | 287.13K | -287.13K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 9.09% | 9.09% | 6.85% | 6.85% |
| Revenue | N/A | N/A | N/A | N/A |